Acute posterior multifocal placoid pigment epitheliopathy (APMPPE).
APMPPE
Acute posterior multifocal placoid pigment epitheliopathy
Imaging
Optical coherence tomography angiography
Placoid epiteliopathy
Journal
Journal of ophthalmic inflammation and infection
ISSN: 1869-5760
Titre abrégé: J Ophthalmic Inflamm Infect
Pays: Germany
ID NLM: 101553216
Informations de publication
Date de publication:
01 Nov 2021
01 Nov 2021
Historique:
received:
17
08
2021
accepted:
30
08
2021
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
16
9
2021
Statut:
epublish
Résumé
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare inflammatory eye disease, affecting the inner choroid and the outer retina. Recent advances in multimodal imaging have been important in the understanding of the pathophysiology of the disease, allowing a better characterization of the morphology of this condition. Narrative review. In this review, a comprehensive overview of clinical features, imaging findings, treatment management, and long-term outcomes of patients with APMPPE will be provided. Although APMPPE was originally believed to be a self-limited condition with a good prognosis, the disease can be recurrent and result in significant loss of vision function. Fundus imaging plays an important role in the diagnosis and management of the disease, allowing to evaluate response to treatment and onset of complications.
Sections du résumé
BACKGROUND
BACKGROUND
Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a rare inflammatory eye disease, affecting the inner choroid and the outer retina. Recent advances in multimodal imaging have been important in the understanding of the pathophysiology of the disease, allowing a better characterization of the morphology of this condition.
METHODS
METHODS
Narrative review.
RESULTS
RESULTS
In this review, a comprehensive overview of clinical features, imaging findings, treatment management, and long-term outcomes of patients with APMPPE will be provided.
CONCLUSIONS
CONCLUSIONS
Although APMPPE was originally believed to be a self-limited condition with a good prognosis, the disease can be recurrent and result in significant loss of vision function. Fundus imaging plays an important role in the diagnosis and management of the disease, allowing to evaluate response to treatment and onset of complications.
Identifiants
pubmed: 34524577
doi: 10.1186/s12348-021-00263-1
pii: 10.1186/s12348-021-00263-1
pmc: PMC8443720
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
31Informations de copyright
© 2021. The Author(s).
Références
Arch Ophthalmol. 1968 Aug;80(2):177-85
pubmed: 5661882
Retin Cases Brief Rep. 2021 Jul 1;15(4):391-398
pubmed: 30142112
J Ophthalmic Inflamm Infect. 2012 Sep;2(3):125-31
pubmed: 22573398
Ophthalmology. 1995 Dec;102(12):1877-83
pubmed: 9098291
Eye (Lond). 2017 Oct;31(10):1399-1408
pubmed: 28983094
Ocul Immunol Inflamm. 2011 Dec;19(6):426-30
pubmed: 22106911
Retin Cases Brief Rep. 2019 Nov 19;:
pubmed: 31764886
J Clin Exp Ophthalmol. 2016 Jun;7(3):
pubmed: 27482471
Retina. 2009 Jul-Aug;29(7):994-1001
pubmed: 19491729
Rom J Ophthalmol. 2015 Jan-Mar;59(1):52-8
pubmed: 27373117
Am J Ophthalmol. 1975 Dec;80(6):1003-5
pubmed: 173190
Retin Cases Brief Rep. 2020 Jan 27;:
pubmed: 31990820
Case Rep Ophthalmol Med. 2020 Mar 13;2020:7049168
pubmed: 32231829
Am J Ophthalmol Case Rep. 2016 Aug 31;4:60-63
pubmed: 29503928
J Ophthalmic Vis Res. 2011 Oct;6(4):338-43
pubmed: 22454756
Arch Ophthalmol. 1990 May;108(5):698-700
pubmed: 2334328
Diagnostics (Basel). 2021 May 24;11(6):
pubmed: 34073914
Cir Cir. 2016 Mar-Apr;84(2):135-9
pubmed: 26242824
Ocul Immunol Inflamm. 2020 Nov 16;28(8):1223-1238
pubmed: 32976732
Case Rep Ophthalmol Med. 2019 Jul 9;2019:9217656
pubmed: 31380133
Neurologist. 2020 Sep;25(5):131-136
pubmed: 32925484
Br J Ophthalmol. 2010 Mar;94(3):282-3, 363
pubmed: 18728052
J Fr Ophtalmol. 2020 Feb;43(2):e55-e66
pubmed: 31932062
Ophthalmic Surg Lasers Imaging Retina. 2019 Jul 1;50(7):428-436
pubmed: 31344242
J Ophthalmic Inflamm Infect. 2018 Sep 12;8(1):13
pubmed: 30209691
Ocul Immunol Inflamm. 2011 Feb;19(1):42-7
pubmed: 21034311
Semin Ophthalmol. 2012 Sep-Nov;27(5-6):228-35
pubmed: 23163281
Br J Ophthalmol. 1995 Apr;79(4):384-9
pubmed: 7742290
J Clin Neurosci. 2016 Sep;31:76-80
pubmed: 27183958
Retina. 2012 Jul;32(7):1403-10
pubmed: 22466468
Ophthalmic Surg Lasers Imaging Retina. 2016 Jan;47(1):20-6
pubmed: 26731205
Ann Ophthalmol. 1992 May;24(5):169-73
pubmed: 1637125
Br J Ophthalmol. 1988 Jan;72(1):74-7
pubmed: 3342223
Acta Ophthalmol (Copenh). 1994 Feb;72(1):128-33
pubmed: 8017187
Saudi J Ophthalmol. 2014 Apr;28(2):95-103
pubmed: 24843301
Arch Ophthalmol. 1995 Mar;113(3):297-300
pubmed: 7887843
Ophthalmol Retina. 2020 Apr;4(4):454-456
pubmed: 31937472
PLoS One. 2020 Aug 24;15(8):e0238080
pubmed: 32834009
Int Ophthalmol Clin. 2016 Fall;56(4):175-201
pubmed: 27575767
Retina. 1995;15(4):351-2
pubmed: 8545582
Ophthalmol Retina. 2017 Jan - Feb;1(1):77-91
pubmed: 31047399
J Vitreoretin Dis. 2020 Jun 1;4(3):192-201
pubmed: 34084990
J Clin Neurol. 2016 Oct;12(4):460-467
pubmed: 27819416
Curr Opin Ophthalmol. 2004 Dec;15(6):519-30
pubmed: 15523198
Eye (Lond). 2010 Jan;24(1):180-1
pubmed: 19343055
Am J Ophthalmol. 1976 Apr;81(4):403-12
pubmed: 1266918
Int J Retina Vitreous. 2017 Mar 20;3:12
pubmed: 28331634
J Curr Ophthalmol. 2020 Dec 12;32(4):381-389
pubmed: 33553841
Stroke. 1996 May;27(5):996-1001
pubmed: 8623125
Ocul Immunol Inflamm. 2020 Sep 23;:1-4
pubmed: 32966152
Eye (Lond). 2021 Jan;35(1):33-51
pubmed: 32678354
Br J Ophthalmol. 1996 Feb;80(2):186
pubmed: 8814755
Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1219-23
pubmed: 16639621
Retin Cases Brief Rep. 2019 Nov 08;:
pubmed: 31725490
Retina. 2005 Dec;25(8):1109-12
pubmed: 16340549
Retina. 2017 Nov;37(11):2084-2094
pubmed: 28151840